AI-driven lab in Shanghai identifies novel non-opioid pain drug candidate
Researchers using an automated laboratory in Zhangjiang, Shanghai encountered an unexpected experimental result that led to the identification of a new non-opioid pain treatment candidate. The discovery reportedly emerged from AI-assisted experimentation rather than traditional hypothesis-driven research, suggesting machine learning systems can surface biological insights humans might not have anticipated.